Cargando…
A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control
AIMS/HYPOTHESIS: Metabolomics has opened new avenues for studying metabolic alterations in type 2 diabetes. While many urine and blood metabolites have been associated individually with diabetes, a complete systems view analysis of metabolic dysregulations across multiple biofluids and over varying...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499109/ https://www.ncbi.nlm.nih.gov/pubmed/26049400 http://dx.doi.org/10.1007/s00125-015-3636-2 |
_version_ | 1782380726343172096 |
---|---|
author | Yousri, Noha A. Mook-Kanamori, Dennis O. Selim, Mohammed M. El-Din Takiddin, Ahmed H. Al-Homsi, Hala Al-Mahmoud, Khoulood A. S. Karoly, Edward D. Krumsiek, Jan Do, Kieu Thinh Neumaier, Ulrich Mook-Kanamori, Marjonneke J. Rowe, Jillian Chidiac, Omar M. McKeon, Cindy Al Muftah, Wadha A. Kader, Sara Abdul Kastenmüller, Gabi Suhre, Karsten |
author_facet | Yousri, Noha A. Mook-Kanamori, Dennis O. Selim, Mohammed M. El-Din Takiddin, Ahmed H. Al-Homsi, Hala Al-Mahmoud, Khoulood A. S. Karoly, Edward D. Krumsiek, Jan Do, Kieu Thinh Neumaier, Ulrich Mook-Kanamori, Marjonneke J. Rowe, Jillian Chidiac, Omar M. McKeon, Cindy Al Muftah, Wadha A. Kader, Sara Abdul Kastenmüller, Gabi Suhre, Karsten |
author_sort | Yousri, Noha A. |
collection | PubMed |
description | AIMS/HYPOTHESIS: Metabolomics has opened new avenues for studying metabolic alterations in type 2 diabetes. While many urine and blood metabolites have been associated individually with diabetes, a complete systems view analysis of metabolic dysregulations across multiple biofluids and over varying timescales of glycaemic control is still lacking. METHODS: Here we report a broad metabolomics study in a clinical setting, covering 2,178 metabolite measures in saliva, blood plasma and urine from 188 individuals with diabetes and 181 controls of Arab and Asian descent. Using multivariate linear regression we identified metabolites associated with diabetes and markers of acute, short-term and long-term glycaemic control. RESULTS: Ninety-four metabolite associations with diabetes were identified at a Bonferroni level of significance (p < 2.3 × 10(−5)), 16 of which have never been reported. Sixty-five of these diabetes-associated metabolites were associated with at least one marker of glycaemic control in the diabetes group. Using Gaussian graphical modelling, we constructed a metabolic network that links diabetes-associated metabolites from three biofluids across three different timescales of glycaemic control. CONCLUSIONS/INTERPRETATION: Our study reveals a complex network of biochemical dysregulation involving metabolites from different pathways of diabetes pathology, and provides a reference framework for future diabetes studies with metabolic endpoints. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-015-3636-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-4499109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-44991092015-07-16 A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control Yousri, Noha A. Mook-Kanamori, Dennis O. Selim, Mohammed M. El-Din Takiddin, Ahmed H. Al-Homsi, Hala Al-Mahmoud, Khoulood A. S. Karoly, Edward D. Krumsiek, Jan Do, Kieu Thinh Neumaier, Ulrich Mook-Kanamori, Marjonneke J. Rowe, Jillian Chidiac, Omar M. McKeon, Cindy Al Muftah, Wadha A. Kader, Sara Abdul Kastenmüller, Gabi Suhre, Karsten Diabetologia Article AIMS/HYPOTHESIS: Metabolomics has opened new avenues for studying metabolic alterations in type 2 diabetes. While many urine and blood metabolites have been associated individually with diabetes, a complete systems view analysis of metabolic dysregulations across multiple biofluids and over varying timescales of glycaemic control is still lacking. METHODS: Here we report a broad metabolomics study in a clinical setting, covering 2,178 metabolite measures in saliva, blood plasma and urine from 188 individuals with diabetes and 181 controls of Arab and Asian descent. Using multivariate linear regression we identified metabolites associated with diabetes and markers of acute, short-term and long-term glycaemic control. RESULTS: Ninety-four metabolite associations with diabetes were identified at a Bonferroni level of significance (p < 2.3 × 10(−5)), 16 of which have never been reported. Sixty-five of these diabetes-associated metabolites were associated with at least one marker of glycaemic control in the diabetes group. Using Gaussian graphical modelling, we constructed a metabolic network that links diabetes-associated metabolites from three biofluids across three different timescales of glycaemic control. CONCLUSIONS/INTERPRETATION: Our study reveals a complex network of biochemical dysregulation involving metabolites from different pathways of diabetes pathology, and provides a reference framework for future diabetes studies with metabolic endpoints. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-015-3636-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2015-06-07 2015 /pmc/articles/PMC4499109/ /pubmed/26049400 http://dx.doi.org/10.1007/s00125-015-3636-2 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Yousri, Noha A. Mook-Kanamori, Dennis O. Selim, Mohammed M. El-Din Takiddin, Ahmed H. Al-Homsi, Hala Al-Mahmoud, Khoulood A. S. Karoly, Edward D. Krumsiek, Jan Do, Kieu Thinh Neumaier, Ulrich Mook-Kanamori, Marjonneke J. Rowe, Jillian Chidiac, Omar M. McKeon, Cindy Al Muftah, Wadha A. Kader, Sara Abdul Kastenmüller, Gabi Suhre, Karsten A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control |
title | A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control |
title_full | A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control |
title_fullStr | A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control |
title_full_unstemmed | A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control |
title_short | A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control |
title_sort | systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499109/ https://www.ncbi.nlm.nih.gov/pubmed/26049400 http://dx.doi.org/10.1007/s00125-015-3636-2 |
work_keys_str_mv | AT yousrinohaa asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT mookkanamoridenniso asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT selimmohammedmeldin asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT takiddinahmedh asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT alhomsihala asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT almahmoudkhouloodas asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT karolyedwardd asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT krumsiekjan asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT dokieuthinh asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT neumaierulrich asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT mookkanamorimarjonnekej asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT rowejillian asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT chidiacomarm asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT mckeoncindy asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT almuftahwadhaa asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT kadersaraabdul asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT kastenmullergabi asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT suhrekarsten asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT yousrinohaa systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT mookkanamoridenniso systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT selimmohammedmeldin systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT takiddinahmedh systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT alhomsihala systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT almahmoudkhouloodas systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT karolyedwardd systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT krumsiekjan systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT dokieuthinh systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT neumaierulrich systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT mookkanamorimarjonnekej systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT rowejillian systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT chidiacomarm systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT mckeoncindy systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT almuftahwadhaa systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT kadersaraabdul systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT kastenmullergabi systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol AT suhrekarsten systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol |